SE445803B - Anordning innehallande aktivt kol for avgiftning av en kroppsvetska - Google Patents
Anordning innehallande aktivt kol for avgiftning av en kroppsvetskaInfo
- Publication number
- SE445803B SE445803B SE8103926A SE8103926A SE445803B SE 445803 B SE445803 B SE 445803B SE 8103926 A SE8103926 A SE 8103926A SE 8103926 A SE8103926 A SE 8103926A SE 445803 B SE445803 B SE 445803B
- Authority
- SE
- Sweden
- Prior art keywords
- activated carbon
- particles
- container
- cleaning
- petroleum resin
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title claims description 30
- 239000003245 coal Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 169
- 239000002245 particle Substances 0.000 claims description 48
- 238000004140 cleaning Methods 0.000 claims description 34
- 239000003208 petroleum Substances 0.000 claims description 29
- 239000011347 resin Substances 0.000 claims description 28
- 229920005989 resin Polymers 0.000 claims description 28
- 239000002504 physiological saline solution Substances 0.000 claims description 24
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical group OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 19
- 229960002897 heparin Drugs 0.000 claims description 19
- 229920000669 heparin Polymers 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 12
- 210000001124 body fluid Anatomy 0.000 claims description 11
- 239000010839 body fluid Substances 0.000 claims description 11
- 239000011148 porous material Substances 0.000 claims description 10
- 229920002307 Dextran Polymers 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000010419 fine particle Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 230000004087 circulation Effects 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 8
- 230000035699 permeability Effects 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000000356 contaminant Substances 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 238000004506 ultrasonic cleaning Methods 0.000 description 5
- 229930003779 Vitamin B12 Natural products 0.000 description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 4
- 229940109239 creatinine Drugs 0.000 description 4
- 239000011715 vitamin B12 Substances 0.000 description 4
- 235000019163 vitamin B12 Nutrition 0.000 description 4
- 229920001202 Inulin Polymers 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 241000283977 Oryctolagus Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000002429 anti-coagulating effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- DPPFTYBYPWHNRM-UHFFFAOYSA-N 1-(2-methoxy-4-methyl-5-methylsulfanylphenyl)propan-2-amine Chemical compound COC1=CC(C)=C(SC)C=C1CC(C)N DPPFTYBYPWHNRM-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical class [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13946579A JPS5662540A (en) | 1979-10-29 | 1979-10-29 | Washing method of active carbon for purifying body fluid |
| JP13946779A JPS5663358A (en) | 1979-10-29 | 1979-10-29 | Purifier for body fluid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8103926L SE8103926L (sv) | 1981-06-23 |
| SE445803B true SE445803B (sv) | 1986-07-21 |
Family
ID=26472274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8103926A SE445803B (sv) | 1979-10-29 | 1981-06-23 | Anordning innehallande aktivt kol for avgiftning av en kroppsvetska |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4358376A (it) |
| EP (1) | EP0038860B1 (it) |
| AU (1) | AU528671B2 (it) |
| CA (1) | CA1144484A (it) |
| GB (1) | GB2074168B (it) |
| IT (1) | IT1134090B (it) |
| NL (1) | NL185132C (it) |
| SE (1) | SE445803B (it) |
| WO (1) | WO1981001103A1 (it) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0088971B1 (de) * | 1982-03-13 | 1985-06-19 | Roche Diagnostics GmbH | Vorrichtung zum Nachweis von Bakterien, Pilzen und Viren im Blut |
| US5910304A (en) * | 1982-12-13 | 1999-06-08 | Texas A&M University System | Low-dose oral administration of interferons |
| US4724079A (en) * | 1985-01-11 | 1988-02-09 | Gloria Stephan Sale | Water purification process |
| US4820514A (en) * | 1985-12-30 | 1989-04-11 | Texas A&M University System | Low dosage of interferon to enhance vaccine efficiency |
| ZA878295B (en) * | 1986-11-06 | 1988-05-03 | Amarillo Cell Culture Co. Inc. | Treatment of immuno-resistant disease |
| CA1320905C (en) * | 1986-11-06 | 1993-08-03 | Joseph M. Cummins | Treatment of immuno-resistant disease |
| FR2616773B1 (fr) * | 1987-06-19 | 1991-07-05 | Srti Soc Rech Tech Ind | Dispositif individuel portable de traitement d'eau |
| NL9001087A (nl) * | 1990-05-07 | 1991-12-02 | Harimex Ligos Bv | Werkwijze voor het zuiveren van bloedplasma. |
| CN1040690C (zh) * | 1992-09-03 | 1998-11-11 | 惠普公司 | 一种色谱用的固相提取柱 |
| US5639376A (en) * | 1994-01-10 | 1997-06-17 | Hemasure, Inc. | Process for simultaneously removing leukocytes and methylene blue from plasma |
| EP0739232A1 (en) * | 1994-01-10 | 1996-10-30 | Hemasure, Inc. | Device and process for removing leukocytes and viral inactivating agents from blood |
| US5503740A (en) * | 1994-09-20 | 1996-04-02 | Teledyne Industries, Inc. | Filter funnel having releasably mounted reservoir |
| US5935426A (en) | 1997-08-08 | 1999-08-10 | Teledyne Industries, Inc., A California Corporation | Water treatment device with volumetric and time monitoring features |
| JP4150838B2 (ja) * | 1999-11-02 | 2008-09-17 | 株式会社カネカ | 充填物流出防止用フィルタ及びそれを装着した吸着器 |
| EP1356832B1 (en) * | 2001-01-30 | 2012-07-11 | Kaneka Corporation | Body fluid processor enabling direct hemoperfusion |
| US7326334B2 (en) | 2003-10-01 | 2008-02-05 | Instapure Brands, Inc. | End-of-faucet filter |
| USD533622S1 (en) | 2003-10-01 | 2006-12-12 | Water Pik, Inc. | End-of-faucet filter |
| CN1988926B (zh) * | 2004-07-23 | 2010-05-05 | 株式会社钟化 | 填充有除去了水不溶性微粒的吸附材料的直接血液灌注用吸附器、与除去了水不溶性微粒的直接血液灌注用吸附材料的取得方法 |
| US7563410B2 (en) * | 2004-10-19 | 2009-07-21 | Agilent Technologies, Inc. | Solid phase extraction apparatus and method |
| GB0921528D0 (en) | 2009-12-09 | 2010-01-27 | Mast Carbon Internat Ltd | Carbon and its use in blood cleansing applications |
| PL3241576T3 (pl) * | 2011-11-07 | 2020-01-31 | Delcath Systems, Inc. | Aparat do usuwania związków chemioterapeutycznych z krwi |
| WO2017151797A1 (en) | 2016-03-02 | 2017-09-08 | Exthera Medical Corporation | Method for treating drug intoxication |
| US11911551B2 (en) | 2016-03-02 | 2024-02-27 | Exthera Medical Corporation | Method for treating drug intoxication |
| KR20220009400A (ko) | 2019-05-16 | 2022-01-24 | 엑스테라 메디컬 코퍼레이션 | 내피 글리코칼릭스 구조의 조절 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1601333A (it) * | 1968-12-03 | 1970-08-17 | ||
| US3725113A (en) * | 1970-12-17 | 1973-04-03 | Research Corp | Blood compatible microencapsulated detoxicants and method for making |
| US3770625A (en) * | 1971-04-19 | 1973-11-06 | Carborundum Co | Removal of virus from fluids |
| DE2304512B1 (de) * | 1973-01-31 | 1974-06-27 | B. Braun Melsungen Ag, 3508 Melsungen | Vorrichtung zum Filtern von Blut |
| JPS564271B2 (it) * | 1973-02-27 | 1981-01-29 | ||
| US3888250A (en) * | 1973-07-02 | 1975-06-10 | Becton Dickinson Co | Disposable hemoperfusion assembly for detoxification of blood and method therefor |
| US4169051A (en) * | 1976-06-22 | 1979-09-25 | Eisai Co., Ltd. | Blood purification with coated activated carbon spheres |
| SE410784B (sv) * | 1977-12-16 | 1979-11-05 | Gambro Dialysatoren | Kolonn for avlegsnande av gifter och/eller andra emnen ur en vetskeblandning och/eller for jonbyte |
| JPS5510971A (en) * | 1978-07-12 | 1980-01-25 | Sumitomo Chemical Co | Blood purifying device |
-
1980
- 1980-10-27 US US06/200,915 patent/US4358376A/en not_active Expired - Lifetime
- 1980-10-28 CA CA000363428A patent/CA1144484A/en not_active Expired
- 1980-10-29 IT IT25638/80A patent/IT1134090B/it active
- 1980-10-29 NL NLAANVRAGE8020407,A patent/NL185132C/xx not_active IP Right Cessation
- 1980-10-29 WO PCT/JP1980/000268 patent/WO1981001103A1/ja not_active Ceased
- 1980-10-29 AU AU64828/80A patent/AU528671B2/en not_active Ceased
- 1980-10-29 GB GB8120004A patent/GB2074168B/en not_active Expired
-
1981
- 1981-05-04 EP EP80902124A patent/EP0038860B1/en not_active Expired
- 1981-06-23 SE SE8103926A patent/SE445803B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU6482880A (en) | 1981-05-07 |
| IT1134090B (it) | 1986-07-24 |
| EP0038860A1 (en) | 1981-11-04 |
| EP0038860A4 (en) | 1982-04-22 |
| NL185132C (nl) | 1990-02-01 |
| EP0038860B1 (en) | 1984-07-18 |
| GB2074168A (en) | 1981-10-28 |
| IT8025638A0 (it) | 1980-10-29 |
| NL8020407A (nl) | 1981-09-01 |
| AU528671B2 (en) | 1983-05-05 |
| WO1981001103A1 (fr) | 1981-04-30 |
| CA1144484A (en) | 1983-04-12 |
| SE8103926L (sv) | 1981-06-23 |
| GB2074168B (en) | 1983-05-18 |
| US4358376A (en) | 1982-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE445803B (sv) | Anordning innehallande aktivt kol for avgiftning av en kroppsvetska | |
| CA1328843C (en) | Blood cleaning hollow fiber membrane, method for cleaning blood, and apparatus therefor | |
| JP4587213B2 (ja) | 生体適合性ポリマーおよびそれを用いた白血球選択除去フィルター材 | |
| US5498336A (en) | Leukocyte-removing filter and leukocyte-removing apparatus furnished therewith | |
| GB1580546A (en) | Biocompatible hemoperfusion system | |
| EP1016426B1 (en) | Leukocyte-removing filter material | |
| JP6497318B2 (ja) | 血小板浮遊液洗浄用の中空糸膜モジュール | |
| US20040104165A1 (en) | Filter for processing blood and process for producing the same | |
| WO2003047655A1 (fr) | Filtre pour l'elimination selective de leucocytes | |
| JP4707810B2 (ja) | 内因性カンナビノイドの吸着材、吸着除去方法および吸着器 | |
| JPS62181056A (ja) | ヘパリン被覆された濾過要素を有する血液濾過装置 | |
| JPH06510455A (ja) | ガスプラズマ処理多孔性媒体及びそれを使用した分離方法 | |
| JP5696527B2 (ja) | 血漿分離膜モジュールを用いた血漿の分離方法 | |
| JPH0556987B2 (it) | ||
| AU638168B2 (en) | Blood cleaning hollow fiber membrane, method for cleaning blood, and apparatus therefor | |
| EP0570232A2 (en) | Microporous polysulfone supports suitable for removal of low density lipoprotein-cholesterol | |
| EP0371178A1 (en) | Method for producing a blood cleaning apparatus with hollow fiber membranes | |
| JPS606662B2 (ja) | 吸着型人工臓器 | |
| JPH03242152A (ja) | 血液処理装置 | |
| JPS5958041A (ja) | ポリスルホン多孔膜の製造方法 | |
| JP3147343B2 (ja) | 親水性フイルター材料の製造方法 | |
| JPS5826819A (ja) | 多孔性ガラスからなる低密度リポ蛋白質吸着剤 | |
| JPS637788B2 (it) | ||
| JPS6341616B2 (it) | ||
| CN116539738A (zh) | 脂溶性维生素固定化量测定方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8103926-5 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8103926-5 Format of ref document f/p: F |